24 September 2026
Swissmedic: Swissmedic Portal Release – New Features Available from 23 September 2026
This release includes the submission of major changes (establishment licences) in accordance with art. 41 para. 2 of the Medicinal Products Licensing Ordinance (MPLO), as well as the viewing of specialist data for complementary medicines in the notification procedure (Chapter 7 KPTPO (Komplementär- und Phytoarzneimittelverordnung, KPAV); basic company dossier, master dossier and medicines (single notifications)) by the marketing authorisation holders.
For more information, see here.
More News
-
-
Swissmedic: New strategic Approach to minimizing Animal Testing in the Development of Medicinal Products
-
European Medicines Agency: New oral GLP-1 Medicine for Weight Management and Type 2 Diabetes
-
Swissmedic: The new Pharmacopoea Helvetica 13
-
FOPH: Capital Income of Health Insurers for Premium Reduction – current voluntary System deemed sufficient
-
Swissmedic: Haemovigilance Annual Report 2025
-
Decision C-6534/2024 of 13 October 2026
-
Swissmedic: GMP Compliance by foreign Manufacturers - Simplifications for Industry and Clarification of unresolved Issues
-
European Medicines Agency: Clinical Trial Applications Advice Pilot becomes permanent
-
Swissmedic: Changes to the Guidance document “Import of a human medicinal product according to art. 14 para. 2 and 3 TPA (parallel import)”